Drugs / ONO-7579
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03182257 | Jul 2017 → Jan 2018 | cancer | Ono Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-7579 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03182257 ↗ |
| Modality | Small molecule | — CHEMBL3892052 ↗ |